高壓氧治療長新冠的臨床療效觀察  

Observation on the clinical efficacy of hyperbaric oxygen in the treatment of long-COVID-19

作　　者：毛燕娜 李牧 梁詠詩 梁智華 黎瑋 MOU In Na;LI Mu;LEONG Weng Si;LEONG Chi Wa;LI Wei(Department of Neurology,Kiang Wu Hospital,Macao,China)

机构地区：[1]澳門鏡湖醫院神經内科,中国

出　　处：《镜湖医学》2024年第1期30-31,84,共3页MEDICAL JOURNAL OF KIANG WU

摘　　要：目的分析高壓氧治療“長新冠”患者的療效。方法採用回顧性研究方法,分析鏡湖醫院2023/1~2023/3經高壓氧治療“長新冠”患者的基本資料、臨床症狀、療效情況。結果21例患者中,1例因急性分泌性中耳炎、1例因血壓高不能行高壓氧治療,餘19例患者完成6~10次高壓氧治療,18例有效,1例無效,提示94.7%患者有效。結論高壓氧對“長新冠”治療有效,並是一種安全的非藥物治療方法,值得臨床推廣。Objective Toanalyze the effect of hyperbaric oxygen therapy for long-COVID-19.Methods A retrospective research method was used to analyze the basic information,clinical symptoms,and effect of patients with long-COVID-19 treated with hyperbaric oxygen in Kiang Wu Hospital from January 2023 to March 2023.Results Among the 21 patients,1 patient could not continue hyperbaric oxygen therapy due to acute secretory otitis media and 1 patient due to high blood pressure.The remaining 19 patients completed 6 to 10 rounds of hyperbaric oxygen therapy,18 cases were effective,and 1 case was ineffective,about 94.7%patients were effective.Conclusion Hyperbaric oxygen an effective and safe non-drug treatment for long-COVID-19,and it is worthy of clinical promotion.

关 键 词：長新冠 高壓氧治療 療效 

分 类 号：R563.1[医药卫生—呼吸系统]